Skip to main content
TipRanks
Go Ultimate75% OFF

Proteome Sciences (PRM) Stock Statistics & Valuation Metrics

3 Followers

Total Valuation

Proteome Sciences has a market cap or net worth of GBX 4.77M. The enterprise value is GBX 20.50M.

Market Cap
GBX 4.77M
Enterprise Value
GBX 20.50M

Share Statistics

Proteome Sciences has 350,724,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
350,724,900
Owned by Insiders
24.80%
Owned by Institutions
―

Financial Efficiency

Proteome Sciences’s return on equity (ROE) is 0.32 and return on invested capital (ROIC) is -34.27%.

Return on Equity (ROE)
0.32
Return on Assets (ROA)
-0.37
Return on Invested Capital (ROIC)
-34.27%
Return on Capital Employed (ROCE)
0.32
Revenue Per Employee
117.38K
Profits Per Employee
-95.66K
Employee Count
32
Asset Turnover
0.45
Inventory Turnover
8.87

Valuation Ratios

The current PE Ratio of Proteome Sciences is -1.86. Proteome Sciences’s PEG ratio is -0.05.

PE Ratio
-1.86
PS Ratio
1.27
PB Ratio
-0.47
Price to FCF
13.00
Price to Operating Cash Flow
10.96
PEG Ratio
-0.05

Income Statement

In the last 12 months, Proteome Sciences had revenue of 3.76M and earned -3.06M in profits. Earnings per share was -0.01.

Revenue
3.76M
Gross Profit
-1.01M
Operating Income
-2.67M
Pretax Income
-3.59M
Net Income
-3.06M
EBITDA
-1.74M
Earnings Per Share (EPS)
-0.01

Cash Flow

In the last 12 months, operating cash flow was 425.00K and capital expenditures -58,000, giving a free cash flow of 367.00K billion.

Operating Cash Flow
425.00K
Free Cash Flow
367.00K
Free Cash Flow per Share
0.00

Dividends & Yields

Proteome Sciences pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
7.69%
Earnings Yield
-49.75%

Stock Price Statistics

Beta
0.19
52-Week Price Change
-17.33%
50-Day Moving Average
1.41
200-Day Moving Average
1.60
Relative Strength Index (RSI)
46.39
Average Volume (3m)
188.53K

Important Dates

Proteome Sciences upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Jul 23, 2026
Next Earnings Date
Apr 01, 2027
Ex-Dividend Date
―

Financial Position

Proteome Sciences as a current ratio of 0.13, with Debt / Equity ratio of -165.46%

Current Ratio
0.13
Quick Ratio
0.09
Debt to Market Cap
1.96
Net Debt to EBITDA
-8.61
Interest Coverage Ratio
-2.88

Taxes

In the past 12 months, Proteome Sciences has paid -530.00K in taxes.

Income Tax
-530.00K
Effective Tax Rate
0.15

Enterprise Valuation

Proteome Sciences EV to EBITDA ratio is -15.14, with an EV/FCF ratio of 53.45.

EV to Sales
5.20
EV to EBITDA
-15.14
EV to Free Cash Flow
53.45
EV to Operating Cash Flow
46.16

Balance Sheet

Proteome Sciences has GBX 1.10M in cash and marketable securities with GBX 15.95M in debt, giving a net cash position of -GBX 14.85M billion.

Cash & Marketable Securities
GBX 1.10M
Total Debt
GBX 15.95M
Net Cash
-GBX 14.85M
Net Cash Per Share
-GBX 0.04
Tangible Book Value Per Share
-GBX 0.04

Margins

Gross margin is -25.36%, with operating margin of -60.56%, and net profit margin of -61.46%.

Gross Margin
-25.36%
Operating Margin
-60.56%
Pretax Margin
-85.49%
Net Profit Margin
-61.46%
EBITDA Margin
-34.38%
EBIT Margin
-60.56%

Analyst Forecast

The average price target for Proteome Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-16.72%
EPS Growth Forecast
36.28%

Scores

Smart Score
―
AI Score
41